tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Johnson & Johnson says Rybrevant Faspro shows strong clinical benefit
PremiumThe FlyJohnson & Johnson says Rybrevant Faspro shows strong clinical benefit
4d ago
J&J weighs sale of DePuy amid private equity interest, Bloomberg says
Premium
The Fly
J&J weighs sale of DePuy amid private equity interest, Bloomberg says
4d ago
Johnson & Johnson preparing for sale of orthopedics unit, Bloomberg says
Premium
The Fly
Johnson & Johnson preparing for sale of orthopedics unit, Bloomberg says
4d ago
Genmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
PremiumThe FlyGenmab sees 2026 revenue $4.065B-$4.395B, consensus $4.13B
6d ago
Johnson & Johnson’s Rybrevant Faspro regimen approved by FDA for NSCLC
Premium
The Fly
Johnson & Johnson’s Rybrevant Faspro regimen approved by FDA for NSCLC
6d ago
Johnson & Johnson presents 12-month pilot-phase data from OMNY-AF study
Premium
The Fly
Johnson & Johnson presents 12-month pilot-phase data from OMNY-AF study
17d ago
PayPal downgraded, UPS upgraded: Wall Street’s top analyst calls
PremiumThe FlyPayPal downgraded, UPS upgraded: Wall Street’s top analyst calls
26d ago
Johnson & Johnson upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Johnson & Johnson upgraded to Overweight from Equal Weight at Morgan Stanley
27d ago
J&J confirms FDA approves quadruplet regimen for multiple myeloma
Premium
The Fly
J&J confirms FDA approves quadruplet regimen for multiple myeloma
27d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100